On Wednesday, Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), added 0.28% and closed at $28.55 in the last trading session. The last trading range of the stock ranges between $27.91 and $29.97. ACADIA Pharmaceuticals Inc. (ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in central nervous system disorders, recently declared the initiation of ADVANCE, a Phase II study to evaluate pimavanserin for adjunctive treatment in patients with negative symptoms of schizophrenia. Studies show that about 40 to 50 percent of schizophrenia patients suffer from prominent negative symptoms. There is presently no drug approved by the U.S. Food and Drug Administration for the treatment of these negative symptoms. As a selective serotonin inverse agonist (SSIA), pimavanserin is a new class of antipsychotic medication with a distinct mechanism of action targeting serotonergic 5-HT2A receptors while avoiding activity at dopamine and other receptors commonly targeted by other antipsychotics.

58.com Inc (ADR)(NYSE:WUBA), jumped 0.54% and closed at $31.39 in the last trading session. The last trading range of the stock ranges between $30.90 and $32.42. The company’s Market capitalization is $4.44 Billion with the total Outstanding Shares of 232.51 million. 58.com Inc. operates an online marketplace for local merchants and consumers in the Peoples Republic of China. Its online marketplace facilitates local merchants and consumers to connect, share information, and conduct business. The companys online marketplace contains local information in about 485 cities in various content categories, counting jobs, real estate, used goods, automotive, and yellow pages. It offers membership services, such as merchant certification and listing benefits, in addition to display of online storefronts; and online marketing services comprising listing services, such as real-time bidding and priority listing, and marketing services through partnershipwith third party Internet companies.